The Pivotal Transactions Portfolio
While much of our work in this space is highly confidential, we are pleased to showcase a selection of our completed projects on this page. In the past 3 years, we have worked with over 170 companies, completing strategic reviews, feasibility studies, sell-side transactions, and buy-side projects. Many clients return to us regularly as they progress along their M&A trajectory.
We support a broad set of transactions, including:
- Mergers
- Acquisitions – share or asset purchases
- Management-led buyouts
- Disposals (assets and stock)
- Specialist Commercial Due Diligence (CDD) to support internal M&A divisions
Pivotal Scientific staff members have personal relationships with an extensive cohort of life science companies and their owners, from manufacturers to distributors, and resellers and regularly work with over 30 private equity and investment organizations, further extending our network. We are therefore ideally placed to promote conversations and introductions between parties of all interests. Explore our portfolio of successful M&A projects below.
Click on each logo to learn more about the strategic reasons behind the acquisitions or divestitures, and how Pivotal Scientific played a pivotal role in facilitating these transactions.
